What has been reported in the literature so far regarding COVID-19 vaccine-related lymphadenopathy?
As of March 2021, at least 20 articles have been published illustrating or discussing COVID-19 vaccine-related lymphadenopathy, with 18 of these articles published in imaging journals. The earliest publications occurred in the field of breast imaging, where vaccine-induced lymphadenopathy was cited as a cause of unilateral axillary lymphadenopathy. Other imaging subspecialities citing this side effect included nine articles in nuclear medicine, and one article in cardiothoracic imaging. In most publications so far, there has only been one or a very small number of patients reported on; one of the largest groups of patients reported on is 23 patients with axillary adenopathy who had undergone breast imaging [6]. Journals which have published on this subject include Radiology, American Journal of Roentgenology, European Journal Nuclear Medicine and Molecular Imaging, Clinical Nuclear Medicine and Journal of the American College of Radiology (JACR). The majority of these articles reported lymphadenopathy as a side effect after the two-dose COVID-19 Pfizer or Moderna vaccines with two recent articles citing vaccine-induced lymphadenopathy with the Oxford-AstraZeneca vaccine, currently only given as one-dose in the United Kingdom, with the second dose planned for delayed administration. The location of the lymphadenopathy was primarily axillary with four articles reporting cervical lymphadenopathy. The lymphadenopathy can be visualized on multiple modalities with most published cases demonstrated on US, followed by PET, MRI, mammography, and CT.
This sounds related:
Pasted from: https://pubs.rsna.org/doi/10.1148/rycan.2021210038
Good catch. In this case, I came across nothing to support a connection between the vax and the cervical cancer mentioned in the video.